Journal
ATHEROSCLEROSIS
Volume 184, Issue 1, Pages 233-234Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2005.08.021
Keywords
rosuvastatin; fatty liver disease; steatosis; anticholesteremic agents